記住我
Figure 2. HepCare Plus Model.
Table 1. Demographics of HepCare Plus Hepatitis C virus (HCV) RNA Positive Individuals.
Table 1. Demographics of HepCare Plus Hepatitis C virus (HCV) RNA Positive Individuals.
% (n) (N = 109)Gender ⮚Male76% (n = 83) ⮚Female24% (n = 26)Age, years (IQR) ⮚Median age43 (39–48)Co-infection with HIV4.6% (n = 5)Aware of positive HCV status >1 year prior to screening *85.1% (80) *Referral Source ⮚General Practices23.9% (n = 26) ⮚Peer Facilitated22.9% (n = 25) ⮚Hospital Referral (Inpatient/Outpatient)21.1% (n = 23) ⮚Homeless Services20.2% (n = 22) ⮚Addiction Services11.9% (n = 13)Treating Service at Mater Misericordiae University Hospital ⮚Infectious Disease Clinic87.2% (n = 95) ⮚Liver Centre12.8% (n = 14)Table 2. Cascade of care results.
Table 2. Cascade of care results.
Number of Individuals (%)Of those who were assessed for treatment (n = 109) ⮚Initiated treatment as of 3 November 2022100 (91.7%) ⮚Due to commence treatment3 (2.8%) ⮚Treatment deferred1 (0.9%) ⮚Lost to follow up5 (4.6%)Of those who initiated treatment (n = 100) ⮚Completed treatment with SVR * as of 3 November 202268 (68%) ⮚Completed treatment with no follow up SVR30 (30%) ⮚Defaulted treatment2 (2%)Table 3. Comparison of Hepatitis C Virus (HCV) treatment figures.
Table 3. Comparison of Hepatitis C Virus (HCV) treatment figures.
YearHepCare PlusMMUH TotalNational Figures2022 *132213320214380554202024925672019 **2079344Total1002731598
留言 (0)